Soul Shining Trademark - Published for Opposition

USPTO published trademark application TM99736811 for SOUL SHINING on April 1, 2026. The application covers downloadable e-books and printed books related to energy healing services, as well as vibrational energy healing services. This publication initiates the opposition period during which third parties may challenge registration.

THE SHIPSHAPE SHIPMATES Trademark Application

USPTO received trademark application TM99736810 for THE SHIPSHAPE SHIPMATES covering downloadable children's content including audio stories, e-books, workbooks, and coloring books. Application filed March 31, 2026 under Intent to Use basis.

SYMMICRO Trademark Application for Automated Material Handling

USPTO published trademark application TM99736800 for SYMMICRO covering Class 009 automated material handling systems, robotic transport vehicles, industrial robots, and related computer software. The application is filed under Intent-to-Use basis for goods and services including automated storage and retrieval systems, inventory management software, and robotic fulfillment systems for e-commerce.

THE SOCIAL EDIT STUDIO Trademark Application

USPTO published trademark application TM99736798 for "THE SOCIAL EDIT STUDIO" covering downloadable educational materials, online courses, webinars, coaching, and training services in social media marketing and content creation. The application was filed March 31, 2026, and published for opposition April 1, 2026. This is a routine trademark publication notice initiating the standard opposition period.

Archer Command trademark application, aviation AI software, April 1st

Archer Command trademark application, aviation AI software, April 1st

Polymer Nanoparticle Compositions for NF1 Treatment

The USPTO published patent application US20260090998A1 covering methods of using block copolymer nanoparticles for delivering nucleic acids to treat Neurofibromatosis Type 1 (NF1). The application (filed October 2, 2025) names 12 inventors and discloses compositions and methods for in vivo therapeutic delivery using polymer nanoparticles.

Delayed Release IBD Treatment Composition

Aihol Corporation filed patent application US20260090996A1 for a delayed-release oral pharmaceutical composition containing mesalamine and hyaluronan layers for treating inflammatory bowel disease. The USPTO published the application on April 2, 2026, with Application No. 19399068 and a filing date of November 24, 2025. This patent covers novel multi-layer coating technology for targeted drug delivery to the colon.

Orodispersible Estetrol Dosage Unit Patent

USPTO published patent application US20260090995A1 by ESTETRA SRL covering an orodispersible solid pharmaceutical dosage unit containing estetrol particles (0.1-25 wt.%) for sublingual, buccal, or sublabial administration. The dosage unit weighs 30-1,000 mg, contains at least 100 μg of estetrol component, and is manufactured via wet granulation of particles sized 2-50 μm. Application No. 19340502 was filed September 25, 2025.

Cannabinoid Emulsion Compositions for Treating Ophthalmic Conditions

Rhodes Technologies published patent application US20260090988A1 for stable cannabinoid emulsion compositions designed for ocular delivery to treat ophthalmic conditions including glaucoma. The application, filed July 29, 2025, and published April 2, 2026, names inventors Ping Chang, Zhenze Hu, and Yuanyuan Tao. This publication represents a patent application only and does not grant enforceable patent rights.

Aspirin Oral Mucosal Formulations

USPTO published patent application US20260090985A1 for oral mucosal aspirin formulations (91-200mg micronized) with buffer and surfactant components. The application, filed by inventor James Dzandu, covers sublingual and buccal delivery formulations with pH ≤3. No regulatory obligations or compliance deadlines are imposed by this patent publication.